Elanco Animal Health Incorporated Common Stock (NY:ELAN)

22.67 +0.53 (+2.39%)

Delayed Quote Updated: 12:39 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Elanco Confirms Date and Conference Call for First Quarter 2022 Financial Results Announcement

April 14, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Why Is Ginkgo Bioworks (DNA) Stock Up Today? ↗

April 13, 2022

Biotechnology company Ginkgo Bioworks has a host of promising collaboration announcements. DNA stock is up as a result.

Via InvestorPlace

Elanco Breaks Ground on State-of-the-Art Campus, Creating Indianapolis’ Newest Landmark

April 12, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Elanco Animal Health Incorporated Announces Early Results of Tender Offer and Increase in Tender Cap for 2023 Notes

April 12, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

Elanco, Ginkgo Bioworks Launch BiomEdit, Microbiome-Focused Animal Health Firm ↗

April 11, 2022

Elanco Animal Health Incorporated (NYSE: ELAN) and Ginkgo Bioworks Holdings Inc (NYSE: DNA) have launched BiomEdit, a microbiome innovation company....

Via Benzinga

Elanco Animal Health Incorporated Announces Tender Offer for 2023 Notes

March 29, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Elanco Expands Commitment to Creating Shared Value, Launches New Initiative Empowering Small-Scale Producers in Sub-Saharan Africa

March 16, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Elanco Animal Health's Q4 Earnings Beat Expectation, FY22 Sales Guidance Trail Estimates ↗

February 24, 2022

Elanco Animal Health Inc (NYSE: ELAN) has reported Q4 EPS of $0.21 higher than $0.12 reported a year ago, surpassing analysts' view of $0.17. Revenue was $1.11...

Via Benzinga

Elanco Animal Health Reports Fourth Quarter and Full Year 2021 Results

February 24, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Elanco Announces the Addition of Rajeev (Bobby) Modi to Lead U.S. Pet Health

February 22, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Elanco to Participate in the Cowen 42nd Annual Health Care Conference

February 21, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Elanco Adds New Tools to Advance U.S. Livestock Sustainability Efforts

February 07, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Elanco to Participate in the BofA Securities 2022 Virtual Animal Health Summit

February 04, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2021 Financial Results Announcement

February 03, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Elanco's Long-Acting Transdermal Buprenorphine for Cats Gains FDA Approval ↗

January 21, 2022

The FDA has approved Elanco Animal Health Inc (NYSE: ELAN) Zorbium (buprenorphine transdermal solution) to control postoperative pain associated with surgical...

Via Benzinga

Elanco’s ZORBIUM™ (Buprenorphine Transdermal Solution) – the First Long-Acting Transdermal Buprenorphine for Cats - Gains U.S. Approval

January 20, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Elanco to Participate in the 40th Annual J.P. Morgan Healthcare Conference

January 04, 2022

From Elanco Animal Health Incorporated

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

January 07, 2022

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...

Via Benzinga

4 Stocks Insiders Are Buying ↗

December 03, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...

Via Benzinga

Elanco To Lay Off 20% Senior Management In Organizational Restructure ↗

November 30, 2021

Elanco Animal Health Incorporated (NYSE: ELAN) will consolidate commercial operations for Elanco International and Elanco Europe into one organization under Ramiro...

Via Benzinga

Elanco Announces Changes to Simplify Organizational Structure, Drive Profitable Growth and Focus Investments on Growth and Innovation Opportunities

November 30, 2021

From Elanco Animal Health Incorporated

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021 ↗

November 18, 2021

Upgrades Macquarie upgraded the previous rating for ZTO Express (Cayman) Inc (NYSE:

Via Benzinga

Elanco to Participate in the Evercore ISI 4th Annual HealthCONx Conference

November 16, 2021

From Elanco Animal Health Incorporated

Via Business Wire

Elanco Joins Newly-Formed Consortium Advancing Climate-Neutral Cattle Innovation

November 08, 2021

From Elanco Animal Health Incorporated

Via Business Wire

Elanco Animal Health Incorporated (ELAN) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

ELAN earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill ↗

November 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus NRx's COVID-19 Drug Fails to Get Authorization From FDA Due To...

Via Benzinga

Elanco Animal Health Reports Third Quarter 2021 Results Exceeding Revenue Guidance; Raising Full Year 2021 Revenue Guidance

November 05, 2021

From Elanco Animal Health Incorporated

Via Business Wire

Earnings Scheduled For November 5, 2021 ↗

November 05, 2021

Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEPC) is projected to report earnings for its third quarter. • Healthcare Trust (NYSE:HTA) is...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.